Protective effects of escin against ethanol-induced gastric mucosal injury in rats via regulation of TNF-α/NF-κB signaling pathway
Year: 2026
Type: article
Abstract: Objective Therapeutic options for ethanol (EtOH)-induced gastric mucosal injury remain limited. To provide new drug options, this study investigated the protective mechanisms of escin—a compound known for its anti-inflammatory and anti-edematous properties—against this condition, which are currently unreported. Methods Male Sprague–Dawley rats in the experimental groups were pretreated with vehicle, escin or omeprazole for 3 d, followed by EtOH administration to induce injury. The gastric ulcer index and histopathological scores were compared. Network pharmacology predicted escin targets. Apoptosis proteins, nuclear factor-κB (NF-κB) pathway proteins and inflammatory factors were analyzed by Western blotting, enzyme-linked immunosorbent assay, immunohistochemistry and immunofluorescence, respectively; additionally, the mRNA expression levels of inflammatory factors were quantitatively analyzed using reverse transcription quantitative polymerase chain reaction. An EtOH-induced GES-1 cell injury model was established to evaluate the protective effects of escin. Genes positively regulating the tumor necrosis factor-α (TNF-α)/NF-κB signaling pathway were identified and validated through transcriptome sequencing. Results Escin significantly alleviated the EtOH-induced gastric mucosal damage. Network pharmacology predicted that escin was closely associated with inflammation-related pathways, such as the NF-κB pathway, during the onset and progression of gastric ulcers. Escin significantly mitigated EtOH-induced injury by restoring mucin 5AC, trefoil factor 2 and Occludin; suppressing NF-κB activation; downregulating interleukin (IL)-1β, IL-6 and TNF-α at both protein and mRNA levels; and modulating apoptosis by inhibiting B cell lymphoma 2 (Bcl-2) associated X (Bax)/caspase-3 while promoting Bcl-2 expression. The protective effect of escin against EtOH-induced injury was further validated in cell proliferation assays. Transcriptomic analysis identified 27 inflammation-related genes upregulated by EtOH, of which nine genes including baculoviral IAP repeat containing 3, Bcl3 , suppressor of cytokine signaling 1 ( Socs1 ), Socs3 , C-C motif chemokine ligand 2, C-X3-C motif chemokine ligand 1, Pim-1 proto-oncogene, serine/threonine kinase 1, serum/glucocorticoid regulated kinase 1 and Oncostatin M receptor positively regulated the TNF-α/NF-κB signaling pathway. Subsequent validation showed that escin modulated the protein expression of seven of them. Conclusion Escin exerts a protective effect against EtOH-induced gastric mucosal injury by inhibiting the TNF-α/NF-κB signaling pathway, thereby reducing the expression of inflammatory factors and the level of cell apoptosis. These findings support the potential of escin as a novel therapeutic drug for EtOH-induced gastric mucosal injury. Please cite this article as: Shen Y, Zhao XY, Zhou ZY, Han JL, Zhang HZ, Yin J, Si SP, Ding LJ, Ji L, Zhang YN, Lyu ZF, Tian WY, Lyu JL, Zhu HH, Chen FJ, Zhan Q, An FM. Protective effects of escin against ethanol-induced gastric mucosal injury in rats via regulation of TNF-α/NF-κB signaling pathway. J Integr Med . 2026; Epub ahead of print.
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $1,800
OpenAlex ID: W7233917618
